Skip to content
Catalyst

trehaloseWhat was measured

Measured, with no finding

46 endpoints

Show what was measuredHide what was measured
  • carbohydrate oxidation, drink

    decreases

    a reduced carbohydrate oxidation after trehalose when ingested as a drink

    PMID 19664296 · one of two readings recorded this

  • fat oxidation, drink

    no effect

    no significant differences in fat oxidation between drink were observed

    PMID 19664296 · one of two readings recorded this

  • glucose DeltaAUC with mixed meal

    decreases

    Ingestion of carbohydrates with a mixed meal resulted in a lower peak glucose response and a lower change in area under the curve (DeltaAUC) following trehalose when compared with glucose

    PMID 19664296 · one of two readings recorded this

  • insulin DeltaAUC

    unclear

    Differences in peak insulin response and DeltaAUC were observed with trehalose when compared with glucose during the morning and afternoon

    PMID 19664296 · one of two readings recorded this

  • peak glucose response with mixed meal

    decreases

    Ingestion of carbohydrates with a mixed meal resulted in a lower peak glucose response and a lower change in area under the curve (DeltaAUC) following trehalose when compared with glucose

    PMID 19664296 · one of two readings recorded this

  • peak insulin response

    unclear

    Differences in peak insulin response and DeltaAUC were observed with trehalose when compared with glucose during the morning and afternoon

    PMID 19664296 · one of two readings recorded this

  • Body mass

    increases, p = 0.04

    maltose: 72.8±3.4 vs. 72.1±3.4 kg, P=0.04; trehalose: 74.1±4.8 vs. 73.4±4.7 kg, P=0.02

    PMID 27208415 · one of two readings recorded this

  • Body mass

    increases, p = 0.02

    maltose: 72.8±3.4 vs. 72.1±3.4 kg, P=0.04; trehalose: 74.1±4.8 vs. 73.4±4.7 kg, P=0.02

    PMID 27208415 · one of two readings recorded this

  • Body mass, effect of time

    increases, p = 0.01

    There was a significant effect of time on body mass (F[2,27]=6.58, P=0.01)

    PMID 27208415 · one of two readings recorded this

  • C-reactive protein

    no effect

    C-reactive protein (log10[mg/L]) | −0.21±0.08 | −0.15±0.08 | −0.23±0.09 | −0.27±0.10 | −0.16±0.13 | −0.17±0.11

    PMID 27208415 · one of two readings recorded this

  • Carotid compliance (CC), group-by-time interaction

    no effect, p = 0.39

    this response did not differ between groups (F[1,26]=0.78, P=0.39)

    PMID 27208415 · one of two readings recorded this

  • Carotid compliance (CC)

    decreases, p = 0.03

    a decline in CC with maltose supplementation (0.078±0.006 vs. 0.088±0.009 mm2/mmHg × 10−1, P=0.03)

    PMID 27208415 · one of two readings recorded this

  • Carotid compliance (CC)

    no effect, p = 0.12

    there was not a significant within-group change in CC with trehalose (P=0.12, Figure 8)

    PMID 27208415 · one of two readings recorded this

  • Carotid β-stiffness index

    no effect, p = 0.1

    no differences in β-stiffness index, a less blood pressure dependent measure of large elastic artery stiffness, was observed with either trehalose or maltose supplementation (both P>0.1, Figure 8)

    PMID 27208415 · one of two readings recorded this

  • Change in body mass versus change in oxidized LDL

    increases, p = 0.04

    positive correlation between the change in body mass and the change in oxidized LDL after 12 weeks of supplementation (r=0.39, P=0.04)

    PMID 27208415 · one of two readings recorded this

  • Circulating oxidized LDL, CRP, IL-6 and TNF-α, group-by-time interaction

    no effect, p = 0.1

    these factors did not change differentially across the intervention period in the maltose and trehalose treated groups (all P>0.1, Table 4)

    PMID 27208415 · one of two readings recorded this

  • Energy intake, effect of time

    unclear, p = 0.06

    There was a trend towards a significant effect of time on energy intake in both groups (F[1,26]=3.83, P=0.06)

    PMID 27208415 · one of two readings recorded this

  • Interleukin-6

    no effect

    Interleukin-6 (log10[pg/mL]) | −0.09±0.06 | −0.04±0.06 | −0.05±0.03 | −0.04±0.07 | −0.05±0.08 | −0.07±0.07

    PMID 27208415 · one of two readings recorded this

  • Oxidized LDL change, group randomization controlling for body mass change

    no effect, p = 0.33

    group randomization was not an independent predictor of the change in oxidized LDL (r=0.18, P=0.33)

    PMID 27208415 · one of two readings recorded this

  • Oxidized LDL

    no effect

    Oxidized LDL (U/L) | 46±5 | 42±4 | 42±3 | 45±3 | 44±4 | 46±4

    PMID 27208415 · one of two readings recorded this

  • Percent body fat

    no effect, p = 0.13

    percent body fat did not change significantly across the intervention (F[1,29]=2.49, P=0.13)

    PMID 27208415 · one of two readings recorded this

  • Relative carbohydrate intake

    increases, p = 0.001

    Relative carbohydrate intake was higher at week 12 vs. baseline in the maltose group (57±2 vs. 49±1% total calories, P<0.001)

    PMID 27208415 · one of two readings recorded this

  • Relative carbohydrate intake

    unclear, p = 0.07

    there was a trend for carbohydrate intake to be elevated after 12 weeks of trehalose (55±2 vs. 50±3% total calories, P=0.07)

    PMID 27208415 · one of two readings recorded this

  • Tumor necrosis factor-α

    no effect

    Tumor necrosis factor-α (log10[pg/mL]) | 0.09±0.03 | 0.13±0.03 | 0.12±0.04 | 0.03±0.05 | 0.08±0.04 | 0.09±0.05

    PMID 27208415 · one of two readings recorded this

  • blood glucose concentration after 2-h oral glucose tolerance test

    decreases

    In the trehalose group, blood glucose concentrations after a 2-h oral glucose tolerance test significantly decreased following 12 wk of intake in comparison with baseline values (0 wk)

    PMID 28202842 · one of two readings recorded this

  • change in body weight

    decreases

    the change in body weight, waist circumference, and systolic blood pressure were significantly lower in the trehalose group than in the sucrose group

    PMID 28202842 · one of two readings recorded this

  • change in systolic blood pressure

    decreases

    the change in body weight, waist circumference, and systolic blood pressure were significantly lower in the trehalose group than in the sucrose group

    PMID 28202842 · one of two readings recorded this

  • change in waist circumference

    decreases

    the change in body weight, waist circumference, and systolic blood pressure were significantly lower in the trehalose group than in the sucrose group

    PMID 28202842 · one of two readings recorded this

  • change in alanine aminotransferase (ALT)

    unclear

    there was a significant difference between changes in alanine aminotransferase (ALT) trehalose and placebo groups

    PMID 35045351 · one of two readings recorded this

  • change in cIMT from baseline

    no effect

    we could not demonstrate any significant difference between the trehalose group and control group in changes of cIMT from baseline to 3 months in the overall population

    PMID 35045351 · one of two readings recorded this

  • change in MDS TBR of the index vessel (arterial wall inflammation, 18F-FDG PET/CT)

    no effect

    The MDS TBR change of the index vessel at 3-month follow-up was not significant in treatment and placebo groups

    PMID 35045351 · one of two readings recorded this

  • echocardiographic measurements

    no effect

    No significant changes in echocardiographic measurement were noted after trehalose treatment

    PMID 35045351 · one of two readings recorded this

  • urea level change

    unclear, p = 0.038

    Except for the change in urea level in placebo group (31.00 ± 6.59 vs. 25.60 ± 6.402 P = 0.038)

    PMID 35045351 · one of two readings recorded this

  • blood glucose during the 100-min protocol

    increases, p = 0.05

    blood glucose was higher with maltodextrin compared with the other supplements at all time points (all p < .05)

    PMID 38458180 · one of two readings recorded this

  • blood glucose during the 20-min time trial

    no effect, p = 0.05

    Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05)

    PMID 38458180 · one of two readings recorded this

  • blood lactate during the 20-min time trial

    no effect, p = 0.05

    Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05)

    PMID 38458180 · one of two readings recorded this

  • heart rate during the 20-min time trial

    no effect, p = 0.05

    Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05)

    PMID 38458180 · one of two readings recorded this

  • muscle glycogen content during the 20-min time trial

    no effect, p = 0.05

    Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05)

    PMID 38458180 · one of two readings recorded this

  • ratings of perceived exertion during the 20-min time trial

    no effect, p = 0.05

    Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05)

    PMID 38458180 · one of two readings recorded this

  • total work done, 20-min time trial

    increases, p = 0.01

    trehalose improved time-trial performance compared with placebo (total work done 302 ± 39 vs. 287 ± 48 kJ; p = .01)

    PMID 38458180 · one of two readings recorded this

  • total work done, 20-min time trial

    no effect, p = 0.07

    with no other differences between sessions (all p ≥ .07)

    PMID 38458180 · one of two readings recorded this

  • ataxia severity, time by intervention interaction

    no effect

    There was no interaction effect on the ataxia severity

    PMID 38843619 · one of two readings recorded this

  • executive function, time by intervention interaction

    increases

    There were significant interaction effects for executive function (ƞ2 = 0.28-0.43)

    PMID 38843619 · one of two readings recorded this

  • circulating miRNA expression, hsa-miR-1268a, -3605-3p, -555, and -6511a-3p

    decreases

    Specifically, hsa-miR-1268a, -3605-3p, -555, and -6511a-3p were significantly downregulated, while hsa-miR-324-3p and -539-5p showed significant upregulation

    PMID 40187517 · one of two readings recorded this

  • circulating miRNA expression, hsa-miR-324-3p and -539-5p

    increases

    Specifically, hsa-miR-1268a, -3605-3p, -555, and -6511a-3p were significantly downregulated, while hsa-miR-324-3p and -539-5p showed significant upregulation

    PMID 40187517 · one of two readings recorded this

  • Disease rate ratio for change in ALSFRS-R and survival (composite)

    no effect

    The disease rate ratio for change in ALSFRS-R and survival was 0·87 (95% credible interval 0·665-1·102, posterior probability of superiority 0·877)

    PMID 40409314 · one of two readings recorded this